Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Pfizer Inc."

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Pfizer Inc.."

12 result(s) displayed (1 - 12 of 37)


Mylan beats industry titans to Strides' injectables unit

The transaction, worth up to $1.85 billion, is the third-largest acquisition of an Indian pharmaceuticals company to date. Continue reading

Posted on February 28, 2013 8:12 AM




Promising Onyx may make its own deals

Often mentioned as a takeover candidate, the CEO of the company with a vibrant oncology drug pipeline tells those gathered at the BIO CEO & Investor Conference that it may become an acquirer. Continue reading

Posted on February 12, 2013 3:43 PM




Zoetis IPO has pop

Pfizer's former animal health business fetches a $13 billion valuation as it prices above its target range. Continue reading

Posted on February 1, 2013 4:59 PM




Pfizer targets $12.5B valuation for Zoetis

The animal health business expects to price its IPO at $22 to $25 per share and raise roughly $2.2 billion. Continue reading

Posted on January 18, 2013 12:01 PM




Carlyle exits Qualicaps

Mitsubishi Chemical pays $654 million for the maker of pharmaceutical capsules. Continue reading

Posted on December 26, 2012 11:47 AM




Reckitt challenges Bayer with Schiff tender

The U.K. group offers $1.4 billion for the Salt Lake City company as it seeks to establish a vitamin and nutrition business. Continue reading

Posted on November 16, 2012 9:14 AM




Forest Labs forays into Latin America

The maker of central nervous system therapies forms a strategic alliance with Moksha8 Pharmaceuticals that could ultimately lead to a buyout of the São Paulo-based drugmaker. Continue reading

Posted on October 24, 2012 2:12 PM




Pfizer, AstraZeneca in strategic deal

Pfizer has made a $250 million move to bolster its consumer healthcare division through an agreement with AstraZeneca that could begin a larger relationship between the drugmakers Continue reading

Posted on August 15, 2012 4:33 PM




After drug's collapse, all eyes on Elan

The pharmaceutical company's share price is buoyed by takeover speculation after its Alzheimer's compound fails a clinical trial Continue reading

Posted on August 8, 2012 9:08 AM




After divestiture, all eyes on Pfizer's next move

When the bell finally rang on the long-awaited divestiture of Pfizer Inc.'s nutrition business early Monday, April 23, the only thing that surprised observers was the high price tag. But what investors will likely watch with greater curiosity is where... Continue reading

Posted on April 24, 2012 9:57 AM




Pfizer garners $11.9B for nutrition unit

Nestlé triumphs over Danone with a bid valuing the business at 19.8 times forecast Ebitda Continue reading

Posted on April 23, 2012 10:28 AM




$9B to $10B Nestlé-Pfizer deal looks close

A sale of the nutrition business could be announced as soon as next week. Continue reading

Posted on April 18, 2012 12:46 PM




1 2 3 4 Next

Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Goldman, Sachs & Co. veteran Tracy Caliendo will join Bank of America Merrill Lynch in September as a managing director and head of Americas equity hedge fund services. For other updates launch today's Movers & shakers slideshow.

Video

Fewer deals despite discount debt

When will companies stop refinancing and jump back into M&A? More video

Sectors